GGrantIndex
Sort

141,003 grants matching cytokine

Steady states and cellular transitions associated with carcinogenesis and tumorprogression

$670,576
James R. Heath · Institute For Systems Biology · U01 · FY2020 · CA

Multivalent Toxoid Vaccine for recurrent Staphylococccus aureus disease

$670,570
M. Javad Aman · Abvacc, Inc. · R01 · FY2023 · AI

INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUS

$670,541
Tobias M Hohl · Sloan-Kettering Inst Can Research · R37 · FY2025 · AI

INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUS

$670,541
Tobias M Hohl · Sloan-Kettering Inst Can Research · R37 · FY2024 · AI

Mechanism of Endotoxin's Effect On Allergy Risk

$670,530
Keoki Williams · Henry Ford Health System · R01 · FY2006 · AI

MR-Derived Cerebral Oxygen Metabolism underlying Ischemic Vulnerability in Sickle Cell Disease

$670,529
Andria Lee Ford · Washington University · R01 · FY2023 · HL

Enhancement of Brain Dysfunction in Sepsis Survivors by Alzheimer’s Disease Neuropathology

$670,518
Benjamin Herschel Singer · University Of Michigan At Ann Arbor · R01 · FY2024 · AG

Specific T and B cell responses to candidate Treponema pallidum outer membrane protein vaccine antigens

$670,512
David M Koelle · University Of Washington · U19 · FY2022 · AI

Flow-Activated Calcium Signaling Microdomains in Small Pulmonary Arteries

$670,511
Swapnil K. Sonkusare · University Of Virginia · R01 · FY2025 · HL

ANTI-INFLAMMATORY THERAPEUTICS FOR CARDIOVASCULAR DISEASE

$670,504
Samuel A Wickline · Washington University · R01 · FY2015 · HL

Defining Vascular Functions of Proteoglycans through Chemical Biology Approaches

$670,500
Kuberan Balagurunathan · Virginia Commonwealth University · P01 · FY2016 · HL

Defining Vascular Functions of Proteoglycans through Chemical Biology Approaches

$670,500
Kuberan Balagurunathan · Virginia Commonwealth University · P01 · FY2017 · HL

Role of Hyaluronan in IL-13-mediated COVID-19 Pathology

$670,452
William A Petri · University Of Virginia · R01 · FY2024 · HL

The multiple antibiotic resistance (mar) regulon

$670,415
Stuart B. Levy · Tufts University Boston · R01 · FY2016 · AI

Autoimmunity Center of Excellence (ACE) at Stanford

$670,355
Charles Garrison Fathman · Stanford University · U19 · FY2012 · AI

Targeted therapy in Type 1 diabetes

$670,323
Anna Moore · Massachusetts General Hospital · R24 · FY2014 · DK

Substance P exacerbation of CNS inflammation

$670,258
Ian Marriott · University Of North Carolina Charlotte · R01 · FY2012 · NS

Humoral Mechanisms of Protection from Bacillus anthracis Sepsis

$670,250
A. Darise Farris · Oklahoma Medical Research Foundation · U19 · FY2017 · AI

Role of IRF3 in Energy and Glucose Homeostasis

$670,248
Evan D Rosen · Beth Israel Deaconess Medical Center · R01 · FY2020 · DK

Red blood cell released ATP in disturbed blood flow-initiated site specific vascular inflammation and atherosclerosis

$670,245
Pingnian He · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · HL

Further Development of Multi-Antigen Vaccines for Primary and Secondary Prevention of Bladder Cancer HHSN2612015000361 TO: HHSN26100011 PP: 9/17/2018 to 3/16/2020

$670,206
Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2018 · CA

(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer

$670,182
Anna Karolina Palucka · Jackson Laboratory · R01 · FY2018 · CA

(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer

$670,182
Anna Karolina Palucka · Jackson Laboratory · R01 · FY2020 · CA

Olfactory mucosa repair and defense: neuro-immune mechanisms and therapy

$670,166
Andrew P Lane · Johns Hopkins University · R01 · FY2023 · DC

Development of a Vaccine for HIV-AIDS: Humoral Immunity

$670,082
Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA